Page last updated: 2024-08-24

adenosine and Disease Exacerbation

adenosine has been researched along with Disease Exacerbation in 153 studies

Research

Studies (153)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.65)	18.2507
2000's	11 (7.19)	29.6817
2010's	71 (46.41)	24.3611
2020's	70 (45.75)	2.80

Authors

Authors	Studies
Chen, J; Dai, Y; Ding, X; Fang, Y; Hu, J; Liang, Y; Liu, H; Lu, Z; Ning, Y; Song, N; Teng, J; Zhu, J; Zou, J	1
Chen, X; Dong, J; Gong, W; Guo, B; Jiang, Q; Qin, J; Shao, X; Shen, S; Shi, T; Shi, Y; Zhang, L	1
Chen, L; Jin, Y; Li, L; Ma, C; Ma, Y; Tang, Y; Xing, M; Yang, D; Yang, J; Zhang, M	1
Liu, X; Ma, T; Meng, L; Tian, Z; Wang, J; Wang, X; Zhang, W; Zhang, Y	1
Dong, S; Li, J; Li, X; Liu, H; Wang, J; Zhang, Y	1
He, A; Jia, Y; Kong, G; Liu, R	1
Ding, J; Qian, K; Xia, X; Xu, W	1
Li, W; Qi, S; Wu, X; Yaling, F; Yin, Y; Yuan, H; Zhang, B; Zhao, S	1
Ding, H; Fu, Y; Han, X; Hu, Q; Jiang, Y; Qian, S; Shang, H; Wang, M; Xiong, C; Zhang, Z	1
Effendi, WI; Nagano, T	1
Chao, Y; Ji, W; Jin, H; Lin, S; Min, W; Qi, D; Que, B; Wang, X; Yang, M; Ying, X; Yuan, Z; Zhang, H	1
Andreini, D; Annoni, A; Baggiano, A; Bartorelli, AL; Calligaris, G; Collet, C; Consiglio, E; Conte, E; D'Errico, A; De Martini, S; Di Odoardo, L; Fabbiocchi, F; Fiorentini, C; Formenti, A; Guglielmo, M; Lombardi, F; Magatelli, M; Mancini, ME; Montorsi, P; Muscogiuri, G; Mushtaq, S; Olivares, P; Pepi, M; Pontone, G; Ravagnani, P; Sonck, J; Teruzzi, G; Trabattoni, D	1
Shi, J; Wang, H; Xu, B	1
Bouzidi, A; Cutruzzolà, F; Giardina, G; Macone, A; Magnifico, MC; Marani, M; Paone, A; Rinaldo, S	1
Ahmed, R; Caux, C; Coukos, G; Décombaz, L; Derré, L; Dormond, O; Ercolano, G; Gestermann, N; Harari, A; Ho, PC; Ianaro, A; Jandus, C; Jichlinski, P; Kandalaft, L; Lozano, LE; Mastelic-Gavillet, B; Ménétrier-Caux, C; Navarro Rodrigo, B; Nguyen-Ngoc, T; Romero, P; Speiser, DE; Tawadros, T; Valerio, M; Verdeil, G; Vigano, S; Wang, H	1
Ascierto, PA; Capone, M; Madonna, G; Morello, S; Pinto, A; Turiello, R	1
Chen, L; Chen, Z; Deng, Q; Dinglin, X; Hou, X; Huang, H; Li, D; Ling, Y; Lv, Z; Ma, S; Peng, Y; Wang, H; Wu, Y	1
Chen, X; He, B; Liu, X; Pan, B; Pan, Y; Sun, H; Sun, L; Wang, S; Xia, X; Xu, M; Xu, X; Zeng, K	1
Chen, X; Hao, X; Huang, J; Lan, T; Li, H; Li, J; Liao, H; Liao, M; Liu, H; Wu, H; Xie, K; Xu, L; Yan, X; Yuan, K; Zeng, Y; Zhang, D	1
Cai, J; Cao, M; Chen, Z; Gao, W; Wang, J; Wang, X; Wu, J; Zhang, Y; Zuo, X	1
Chen, P; Ma, L; Qian, Q; Zhao, X; Zhu, Z	1
Fang, J; Li, F; Li, Z; Peng, Y; Zhou, J	1
Cui, X; Fan, Y; Li, J; Ren, Z; Sun, R; Wang, Z; Zhang, D; Zhao, W; Zhu, J	1
Achyut, BR; Arbab, AS; Bollag, RJ; Canning, M; Chang, CS; Cui, Y; Deng, L; Guo, G; Huang, L; Mellor, AL; Munn, DH; Rodriguez, PC; Shi, H; Xu, N; Yu, M	1
Chen, F; Chen, Z; Ge, L; Li, D; Li, J; Li, Z; Song, J; Wang, C; Wang, H; Wang, J; Wu, J; Wu, Y; Zhang, N	1
Lin, C; Ye, J; Zhuang, J	1
Bo, X; Jiang, H; Liu, Z; Qin, S; Qu, N; Tan, C; Wen, G; Zhang, X	1
Dai, C; Ding, H; Jia, C; Su, Y; Zhang, X	1
Ban, Y; Cai, J; Hu, M; Li, G; Li, J; Li, X; Mei, Y; Tan, P; Tan, Y; Xiang, B; Xiong, W; Yi, M; Zeng, Z; Zhou, Y	1
Deng, H; Kidwell, RL; Liang, Z; Xie, Q	1
Guo, Y; Li, C; Liu, J; Mao, S; Yao, X; Zhang, W; Zheng, Z	1
Cong, R; Ji, CJ; Luan, JC; Song, LB; Song, NH; Xia, JD; Zhang, QJ; Zhou, X	1
Ju, S; Kong, S; Tao, M; Wang, T	1
Chen, Y; Gao, W; He, J; Lin, Y; Shu, Y	1
Feng, D; Han, J; Lu, Q; Lv, J; Wu, Q; Yang, H; Yang, X; Yu, H; Yuan, B; Zhou, Z	1
Chen, W; Huang, S; Huang, X; Li, W; Lin, R; Liu, Q; Shen, H; Shi, Y; Wang, H; Wang, J; Xu, S; Yang, L; Yu, J; Zhan, M; Zhang, Z	1
Chen, C; Guo, Y; Hou, C; Liu, J; Sun, Z; Yin, D; Yuan, W; Zhang, L	1
Chen, YC; Huang, GZ; Lv, XZ; Shao, TR; Wu, QQ; Zeng, WS; Zheng, ZN	1
Boonyasirinant, T; Kaolawanich, Y	1
Chen, TQ; Chen, YQ; Chen, ZH; Fang, K; Han, C; Huang, W; Luo, XQ; Sun, LY; Sun, YM; Wang, D; Wang, WT; Zeng, ZC	1
Cheng, J; Deng, L; Meng, Q; Wang, J; Wei, F; Xu, L; Xue, L	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Chang, Z; Li, Z; Liu, Y; Lu, X; Luo, C; Qiao, K; Sun, T; Xu, Z; Yang, C; Zhang, C; Zhang, H	1
He, Y; Shi, Q; Xue, C; Yu, Z; Yuan, X	1
Huo, FC; Pei, DS; Zhu, ZM	1
Du, C; Feng, Y; Lv, C; Yu, S	1
Cheng, T; Duan, L; Gao, S; Gu, Y; Han, X; Jiang, S; Li, Y; Liu, T; Liu, Y; Niu, S; Pan, Y; Peng, B; Shang, L; Sun, M; Tong, Z; Wang, X; Wang, Y; Yang, X; Yang, Z; Ye, Q; Zhang, C; Zhang, N; Zhang, X	1
Hao, L; Li, C; Liu, L; Yang, H; Yin, J; Zhong, J; Zhu, L	1
Li, J; Li, X; Liang, L; Ma, Y; Yang, Y	1
Gao, Y; Gao, Z; Luo, J; Song, W; Yang, K	1
Chu, J; He, F; He, J; Jia, J; Sheng, J; Wan, J; Wang, C; Yin, H; Yin, J; Zhou, M	1
Li, F; Lin, Y; Liu, S; Lv, S; Wang, H; Wang, S	1
Li, M; Wang, S; Zha, X	1
Chen, R; Hou, G; Huang, C; Jiang, B; Li, L; Liu, X; Lu, R; Wang, Y; Yang, Q; Yu, J; Zhao, X	1
Paramasivam, A; Priyadharsini, JV	1
Lou, X; Sun, JJ; Wang, JJ; Wei, YQ	1
Cheng, Y; Dong, H; Wang, M; Wang, S; Xu, H; Zhou, J	1
Huang, C; Jiang, G; Liu, F; Sun, J; Xiao, X; Xie, F; Zhang, H; Zhang, X	1
Dai, XY; Ding, Q; Huang, YZ; Li, Z; Shi, L; Wei, JF; Yang, HY; Zhang, X	1
Gong, Z; Guo, C; He, Y; Li, G; Li, X; Li, Y; Shi, L; Tan, F; Wang, F; Wang, Y; Xiang, B; Xiong, F; Xiong, W; Zeng, Z; Zhang, S; Zhao, M; Zhou, M	1
An, SY; Chai, RC; Chang, X; Chang, YZ; Jiang, T; Pang, B; Wang, YZ; Zhang, KN	1
Chong, T; Guan, Y; Ma, Y; Xu, F; Xue, L; Yang, X; Zhang, P	1
Fang, R; Shi, H; Ye, L	1
Chen, C; Gan, M; Kong, J; Lai, M; Wang, S; Zhang, H; Zhang, Y	1
Dang, C; Liu, S; Zhang, Y; Zhao, T	1
Barr, T; Caligiuri, MA; Chen, J; Chen, Z; Ma, S; Sun, JC; Wang, LS; Yan, J; Yu, J; Zhang, J	1
Lv, Y; Tang, M	1
Li, J; Liu, Y; Ni, B; Wang, F; Wang, H	1
An, SY; Chai, RC; Chang, X; Chang, YH; Chang, YZ; Jiang, T; Pang, B; Wang, YZ; Zhang, KN	1
He, X; Hu, K; Jin, M; Li, G; Liu, W; Song, Y; Wu, X; Xiong, M; Zeng, Z; Zhang, Q; Zhao, D; Zhu, J	1
Liu, Y; Ou, B; Xu, X; Yan, Y; Yang, X; Zhang, J	1
Jiang, XB; Li, XD; Wang, MJ; Wang, X; Wu, YH; Zheng, JL	1
Chen, X; Jiang, J; Li, D; Wang, A; Yang, L	1
Abisambra, JF; Alvarez, VE; Ash, PEA; Boudeau, S; Cheng, JX; Crary, JF; Cruz, AL; Emili, A; Hovde, S; Jiang, L; Kanaan, N; Kuo, MH; Kwan, J; Lei, S; Li, H; Lin, W; Maziuk, BF; Murray, ME; Petrucelli, L; Song, J; van Vliet, E; Verma, M; Wolozin, B; Yang, Z; Zhang, C; Zhao, J	1
Albertsson, P; Eklund, C; Gan, LM; Gao, S; Jeppsson, A; Lerman, A; Matejka, G; Omerovic, E; Svedlund, S; Wittfeldt, A	1
Bax, JJ; Kajander, S; Knuuti, J; Maaniitty, T; Mäki, M; Saraste, A; Stenström, I; Ukkonen, H; Uusitalo, V	1
Alfakih, K; Bosio, F; Chiribiri, A; Dancy, L; Di Giovine, G; Gibbs, T; Ismail, TF; Jeyabraba, S; Marber, M; Razavi, R; Sammut, EC; Schwenke, S; Villa, ADM; Williams, SE	1
Borgognoni, L; Brandani, P; Caporale, R; Di Gennaro, P; Gerlini, G; Pimpinelli, N; Sestini, S; Urso, C	1
Dai, D; Jin, H; Wang, H; Wang, X; Zhu, L	1
Bar-Eli, M; Brooks, D; Calin, G; Fuentes-Mattei, E; Huang, L; Ivan, C; Jones, SJM; Kim, SJ; Lopez-Berenstein, G; Paret, H; Robertson, AG; Rodriguez-Aguayo, C; Shoshan, E; Sood, A; Velazquez-Torres, G; Xie, V	1
Dobson, GP; Letson, HL	1
Fausther, M	1
Cai, Y; Feng, L; Wang, X	1
Du, Z; Jin, Y; Liu, J; Ren, D; Wang, H; Zhang, H	1
Chai, P; Jia, R; Wang, S	1
He, L; Li, J; Wang, X; Xie, H; Xie, L; Yan, H; Ying, Y; Zheng, X	1
Azambuja, JH; Battastini, AMO; Beckenkamp, LR; Braganhol, E; de Oliveira, FH; Fernandes, MC; Figueiró, F; Gelsleichter, NE; Iser, IC; Scholl, JN; Sévigny, J; Spanevello, RM; Stefani, MA; Teixeira, HF; Wink, MR	1
Chen, J; Du, B	1
He, Q; Hong, M; Lei, Y; Li, Y; Liu, N; Ma, J; Ren, X; Wang, Y; Wen, X; Yang, X; Zhang, J; Zhang, P	1
Chen, Z; Dai, Q; Li, J; Lu, Z; Luo, G; Qi, M; Shen, B; Wang, H; Wu, Y; Zheng, Z	1
Chen, B; Li, Y; Song, R; Xu, F; Xue, C	2
Alarcón, S; Niechi, I; Quezada, C; Sobrevia, L; Toledo, F	1
Chen, H; Li, X; Liang, H; Lin, Z; Niu, Y; Sun, L; Wan, A; Wan, G; Wang, Y; Wei, B; Wu, X; Xiong, XF	1
Liu, W; Ning, J; Wu, D; Wu, L; Zhang, D	1
Bai, R; Che, X; Chen, R; Fu, Z; Jia, W; Li, G; Li, M; Li, S; Lin, D; Liu, Z; Mai, D; Pan, L; Su, J; Tan, L; Tan, W; Wang, C; Wu, C; Xie, D; Xu, RH; Ye, H; Ye, Y; Zeng, MS; Zhang, J; Zhao, Q; Zheng, J; Zheng, S; Zheng, Y; Zuo, Z	1
Bracci, C; Horenstein, AL; Malavasi, F; Morandi, F	1
Cheng, YP; Liang, GY; Liu, T; Pu, YP; Shen, B; Sui, J; Xu, SY; Yang, S; Yin, LH; Zhang, XM; Zhang, Y	1
Chen, J; Jia, L; Ma, J; Miao, W; Song, D	1
Chen, RY; Han, CH; Mou, S; Wu, JJ; Xia, L; Xu, Y; Yuan, XD; Zhang, M	1
Bleie, O; Borgeraas, H; Løland, KH; Nordrehaug, JE; Nygård, O; Strand, E; Svardal, A; Ueland, PM	1
Whiteside, TL	1
Chan, TH; Chen, L; Fei, J; Guan, XY; Li, FF; Li, Y; Liu, H; Qiao, JJ; Qin, YR; Zhu, YH	1
Asamitsu, K; Hamano, T; Ito, M; Komatsu, T; Okamoto, T; Yamakawa, T	1
Antonioli, L; Blandizzi, C; Colucci, R; Fornai, M; Haskó, G	1
Correia, AM; Gomes, R; Nascimento, F; Pousinha, PA; Ribeiro, JA; Sebastião, AM	1
Costa, VM; Diniz, C; Fresco, P; Soares, AS	1
Aoki, T; Cilluffo, RR; Guddeti, RR; Kwon, TG; Lennon, RJ; Lerman, A; Lerman, LO; Li, J; Matsuzawa, Y; Widmer, RJ	1
Han, L; Jiang, K; Kang, C; Liu, X; Ning, X; Shi, Z; Zhang, A; Zhang, Q	1
Bar-Eli, M; Birol, I; Braeuer, RR; Brooks, D; Calin, GA; Eterovic, AK; Fidler, IJ; Gershenwald, JE; Huang, L; Hwu, P; Ivan, C; Jones, SJ; Kamiya, T; Kim, SJ; Lee, HJ; Markel, G; Mobley, AK; Mosqueda, M; Nip, KM; Robertson, AG; Salameh, A; Shoshan, E; Sood, AK; Vasquez, ME; Velazquez-Torres, G; Wen, YY; Zhu, K	1
Akula, KK; Boison, D; Coffman, SQ; Lusardi, TA; Masino, SA; Ruskin, DN	1
Mayer, A; Vaupel, P	1
Baumgartner, I; Berger, JS; Blomster, J; Fowkes, FG; Heizer, G; Held, P; Hiatt, WR; Jones, WS; Katona, BG; Mahaffey, KW; Millegård, M; Norgren, L; Patel, MR; Reist, C	1
Allard, B; Beavis, PA; Darcy, PK; Stagg, J	1
Kong, Q; Li, H; Liu, L; Liu, Y; Mu, L; Sun, B; Wang, D; Wang, G; Wang, J; Yin, P; Zhang, Y; Zhao, J; Zhao, P; Zhao, S; Zhao, X; Zou, H	1
Adinolfi, E; Di Virgilio, F; Falzoni, S; Giuliani, AL	1
Fuentes, E; Palomo, I; Sepúlveda, C	1
Alchera, E; Bardina, V; Carini, R; Imarisio, C; Novelli, F; Rolla, S; Valente, G	1
Baillie, TJ; Nicholls, SJ; Sanders, P; Sidharta, S; Steele, PM; Teo, K; Willoughby, S; Worthley, MI; Worthley, SG	1
Chu, DCK; Di Paolo, D; Hardy, T; Leslie, J; Luli, S; Mann, DA; Mann, J; Mendivil, EJ; Moran Salvador, E; Oakley, F; Page, A; Perri, P; Ponzoni, M; Sabater, L; Sharkey, V; Singh, US; Tsukamoto, H; Zeybel, M	1
Cui, Q; He, C; Huang, Y; Li, L; Lu, Z; Qu, Q; Riggs, AD; Shi, H; Shi, Y; Sun, G; Yang, CG; Ye, P	1
Dai, J; Houard, X; Louedec, L; Michel, JB; Philippe, M	1
Barroso, B; Geerlings, M; Hylkema, M; Postma, D; Rutgers, B; ten Hacken, N; Timens, W; Versluis, M; Willemse, B	1
Roa, H; San Martín, R; Sobrevia, L; Troncoso, E; Valladares, D	1
Ballerini, P; Biagioni, F; Buccella, S; Caciagli, F; Ciccarelli, R; Citraro, R; D'Alimonte, I; D'Auro, M; De Sarro, G; Di Iorio, P; Giuliani, P; Jiang, S; Nargi, E; Russo, E	1
Carey, MG; Irani, F; Kasmani, R; Pelter, MM	1
Askew, JW; Carryer, DJ; Gibbons, RJ; Hodge, DO; Miller, TD	1
Kottam, A; Williams, KA	1
Chen, M; Huang, B; Li, F; Li, Y; Liang, Y; Tan, H; Wang, S; Yang, N; Yu, X; Zhang, L	1
Arcelus, S; Avila, MA; Banales, JM; Berasain, C; Corrales, FJ; Fernández-Barrena, MG; Gil-Puig, C; Goñi, S; Juanarena, N; Latasa, MU; Lecanda, J; Lotersztajn, S; Méndez, M; Prieto, J; Recio, JA; Rodríguez-Ortigosa, CM; Urtasun, R	1
Curiel, TJ; Fan, J; Shin, T; Thompson, LF; Wang, L; Zhang, B; Zhang, Y	1
Frick, M; Furundzija, V; Gebker, R; Jahnke, C; Manka, R; Marx, N; Paetsch, I; Schnackenburg, B	1
Bensussan, A; Carriere, M; Delaneau, O; Herbeck, JT; Huë, S; Hulin, A; Jenabian, MA; Kök, A; Lelievre, JD; Lévy, Y; Limou, S; Muhtarova, M; Mullins, JI; Nikolova, M; Schuitemaker, H; Seddiki, N; Younas, M; Zagury, JF	1
Bramanti, P; Cuzzocrea, S; DI Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E; Melani, A; Pedata, F	1
Bhatia, V; Dean, P; Hage, FG; Heo, J; Iqbal, F; Iskandrian, AE	1
Alkadhi, H; Cury, RC; Donati, O; Falk, V; Feuchtner, G; Goetti, R; Leschka, S; Plass, A; Scheffel, H; Schnabl, J; Stolzmann, P; Wieser, M; Wyss, C	1
Buchheiser, A; Burghoff, S; Ding, Z; Ebner, A; Fischer, JW; Köhrer, K; Lindecke, A; Romio, M; Schrader, J; Viethen, C	1
Chinnaiyan, AM; He, S; Kato, K; Kuick, R; Liu, Y; Mani, RS; Marquez, VE; Mineishi, S; Mochizuki, K; Nieves, E; Varambally, S; Wang, J; Xie, F; Zhang, Y	1
Eble, BK; Sachdeva, R	1
Beavis, PA; Darcy, PK; Smyth, MJ; Stagg, J	1
Barrick, CA; Becker, J; Buckley, H; Tessarollo, L; Yanpallewar, SU	1
Borea, PA; Fini, M; Lanza, G; Paradiso, B; Parrilli, A; Targa, M; Varani, K; Vincenzi, F	1
Fukuda, H; Furuhashi, T; Hase, H; Joki, N; Kunimasa, T; Masai, H; Moroi, M; Sugi, K	1
Kunnumpuram, GK; Patel, A	1
Alarcón, S; Jaramillo, C; Muñoz, D; Oyarzún, C; Quezada, C; San Martín, R	1
Franceschi, F; Guieu, RP; Lévy, S; Paganelli, F; Saadjian, AY; Zouher, I	1
Arad, M; Berul, CI; Branco, D; Maguire, CT; Moskowitz, IP; Patel, VV; Seidman, CE; Seidman, JG	1
Ayscue, LH; Jin, A; Lazarowski, E; Mitchell, BS; Ostapkowicz, A; Spychala, J	1
Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW	1
Ivan, E; Jasti, V; Leesar, MA; Wongpraparut, N; Yalamanchili, V	1
Back, SA	1
Feldman, AM; McNamara, DM; Wagner, DR	1
Berdeaux, A; Bruneval, P; Ghaleh, B; Giudicelli, JF; Souktani, R; Tissier, R	1

Reviews

35 review(s) available for adenosine and Disease Exacerbation

Article	Year
Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression. Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:9 Topics: Adenosine; Disease Progression; Humans; Neoplasms; RNA; RNA-Binding Proteins; Transcription Factors	2022
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. International journal of molecular sciences, 2023, Feb-23, Volume: 24, Issue:5 Topics: Adenosine; Disease Progression; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Receptors, Purinergic P1	2023
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Cancer biology & medicine, 2020, 02-15, Volume: 17, Issue:1 Topics: Adenosine; Antineoplastic Agents; Carcinogenesis; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Neoplasms; Oxidoreductases, N-Demethylating; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins	2020
The potential role of RNA N6-methyladenosine in Cancer progression. Molecular cancer, 2020, 05-12, Volume: 19, Issue:1 Topics: Adenosine; Animals; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms	2020
Interaction between N Molecular cancer, 2020, 05-22, Volume: 19, Issue:1 Topics: Adenosine; Animals; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms; RNA, Untranslated	2020
Mechanism of RNA modification N6-methyladenosine in human cancer. Molecular cancer, 2020, 06-08, Volume: 19, Issue:1 Topics: Adenosine; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms	2020
The role of N Molecular cancer, 2020, 06-10, Volume: 19, Issue:1 Topics: Adenosine; Animals; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Neoplasms; RNA, Circular	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
N Cell proliferation, 2020, Volume: 53, Issue:11 Topics: Adenosine; Animals; Disease Progression; Humans; Methylation; Methyltransferases; Neoplasms; RNA, Messenger	2020
N Theranostics, 2021, Volume: 11, Issue:6 Topics: Adenosine; Animals; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Humans; RNA, Messenger; RNA, Untranslated	2021
The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochimica et biophysica acta. Reviews on cancer, 2021, Volume: 1875, Issue:2 Topics: Adenosine; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Stem Cells; RNA, Messenger; Tumor Microenvironment	2021
Emerging role of RNA modification N6-methyladenosine in immune evasion. Cell death & disease, 2021, 03-19, Volume: 12, Issue:4 Topics: Adenosine; Disease Progression; Humans; Immune Evasion; RNA	2021
The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer. Genes, 2021, 03-19, Volume: 12, Issue:3 Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; Epigenesis, Genetic; Humans; Lung Neoplasms; Prognosis; RNA	2021
N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. Journal of experimental & clinical cancer research : CR, 2021, Apr-29, Volume: 40, Issue:1 Topics: Adenosine; Disease Progression; Humans; Neoplasms; Signal Transduction	2021
Understanding the roles of N Neoplasia (New York, N.Y.), 2021, Volume: 23, Issue:6 Topics: Adenosine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; RNA, Messenger	2021
The Role of International journal of biological sciences, 2021, Volume: 17, Issue:9 Topics: Adenosine; Animals; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; RNA, Circular	2021
N International journal of biological sciences, 2021, Volume: 17, Issue:9 Topics: Adenosine; Biomarkers, Tumor; Carcinogenesis; Disease Progression; Humans; Pancreatic Neoplasms; Prognosis; RNA, Messenger	2021
N6-methyladenosine links RNA metabolism to cancer progression. Cell death & disease, 2018, 01-26, Volume: 9, Issue:2 Topics: Adenosine; Animals; Disease Progression; DNA Damage; Humans; Neoplasms; RNA, Long Noncoding; RNA, Neoplasm	2018
Extracellular adenosine: a critical signal in liver fibrosis. American journal of physiology. Gastrointestinal and liver physiology, 2018, 07-01, Volume: 315, Issue:1 Topics: Adenosine; Disease Progression; Humans; Liver Cirrhosis; Myofibroblasts; Signal Transduction	2018
Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia. Critical reviews in oncology/hematology, 2018, Volume: 126 Topics: Adenosine; Carcinogens; Cell Transformation, Neoplastic; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Targeted Therapy; Signal Transduction; Tumor Microenvironment	2018
Novel insights on m Molecular cancer, 2018, 07-21, Volume: 17, Issue:1 Topics: Adenosine; Carcinogenesis; Disease Progression; Gene Regulatory Networks; Humans; Neoplasms; RNA, Messenger	2018
The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinogenesis; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Methylation; Methyltransferases; Molecular Targeted Therapy; Neoplasms; RNA Editing; RNA, Neoplasm	2018
Novel positioning from obesity to cancer: FTO, an m Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:1 Topics: 3' Untranslated Regions; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Body Mass Index; Cell Proliferation; Demethylation; Disease Progression; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Obesity; Oncogenes; Polymorphism, Single Nucleotide; Prognosis; Radiation Tolerance	2019
Functions of RNA N6-methyladenosine modification in cancer progression. Molecular biology reports, 2019, Volume: 46, Issue:1 Topics: Adenosine; Animals; Disease Progression; Humans; Methylation; Neoplasms; RNA	2019
Glioma progression in diabesity. Molecular aspects of medicine, 2019, Volume: 66 Topics: Adenosine; Antineoplastic Agents; Brain Neoplasms; Diabetes Mellitus, Type 2; Disease Progression; Gene Regulatory Networks; Glioma; Humans; Hypoglycemic Agents; Obesity; Risk Factors; Up-Regulation	2019
Functions of RNA N6-methyladenosine modification in cancer progression. Molecular biology reports, 2019, Volume: 46, Issue:2 Topics: Adenosine; Disease Progression; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Processing, Post-Transcriptional	2019
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy. Frontiers in immunology, 2019, Volume: 10 Topics: Adenosine; ADP-ribosyl Cyclase 1; Animals; Antineoplastic Agents, Immunological; Disease Management; Disease Progression; Disease Susceptibility; Drug Resistance, Neoplasm; Energy Metabolism; Humans; Immunomodulation; Membrane Glycoproteins; Metabolic Networks and Pathways; Molecular Targeted Therapy; Multiple Myeloma; Receptors, Purinergic; Signal Transduction	2019
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? Cancer immunology, immunotherapy : CII, 2014, Volume: 63, Issue:1 Topics: Adenosine; Animals; CD4-Positive T-Lymphocytes; Chemoradiotherapy; Dinoprostone; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Inflammation; Lymphocyte Subsets; Neoplasms; T-Lymphocytes, Regulatory; Tumor Escape; Tumor Microenvironment	2014
Immunosuppressive activities of adenosine in cancer. Current opinion in pharmacology, 2016, Volume: 29 Topics: 5'-Nucleotidase; Adenosine; Animals; Antibodies; Antineoplastic Agents; Disease Progression; Drug Design; Humans; Neoplasms; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic	2016
P2 receptors in cancer progression and metastatic spreading. Current opinion in pharmacology, 2016, Volume: 29 Topics: Adenosine; Adenosine Triphosphate; Animals; Disease Progression; Humans; Neoplasm Metastasis; Neoplasms; Receptors, Purinergic P2; Tumor Microenvironment	2016
Role of adenosine A2b receptor overexpression in tumor progression. Life sciences, 2016, Dec-01, Volume: 166 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immune Tolerance; Molecular Targeted Therapy; Neoplasms; Receptor, Adenosine A2B; Tumor Microenvironment; Up-Regulation	2016
Do adenosine receptors offer new therapeutic options for diabetic nephropathy? Current vascular pharmacology, 2009, Volume: 7, Issue:4 Topics: Adenosine; Animals; Diabetic Nephropathies; Disease Progression; Endothelium, Vascular; Humans; Kidney Glomerulus; Microvessels; Nitric Oxide; Receptors, Purinergic P1; Vascular Endothelial Growth Factor A	2009
CD73: a potent suppressor of antitumor immune responses. Trends in immunology, 2012, Volume: 33, Issue:5 Topics: 5'-Nucleotidase; Adenosine; Animals; Disease Progression; Humans; Immune Tolerance; Neoplasms	2012
Targeting adenosine signaling to treatment of diabetic nephropathy. Current drug targets, 2013, Volume: 14, Issue:4 Topics: Adenosine; Animals; Diabetic Nephropathies; Disease Progression; Humans; Receptor, Adenosine A2B; Signal Transduction	2013
Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Mental retardation and developmental disabilities research reviews, 2006, Volume: 12, Issue:2 Topics: Adenosine; Cytokines; Disease Progression; Female; Glutamic Acid; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Leukomalacia, Periventricular; Magnetic Resonance Imaging; Obstetric Labor Complications; Oligodendroglia; Pregnancy; Pregnancy Complications	2006

Trials

4 trial(s) available for adenosine and Disease Exacerbation

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine. PloS one, 2013, Volume: 8, Issue:5 Topics: Adenosine; Aged; Arginine; Coronary Angiography; Coronary Artery Disease; Disease Progression; Ethionine; Female; Folic Acid; Follow-Up Studies; Humans; Lysine; Male; Methylation; Middle Aged; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex	2013
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. American heart journal, 2016, Volume: 175 Topics: Adenosine; Aged; Ankle Brachial Index; Clopidogrel; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Stroke; Ticagrelor; Ticlopidine; Treatment Outcome	2016
Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation, 2002, Jul-30, Volume: 106, Issue:5 Topics: Adenosine; Adolescent; Adult; Aged; Blood Pressure; Demography; Disease Progression; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Stroke Volume; Syncope, Vasovagal; Tilt-Table Test	2002

Other Studies

115 other study(ies) available for adenosine and Disease Exacerbation

Article	Year
METTL14 aggravates podocyte injury and glomerulopathy progression through N Cell death & disease, 2021, 09-27, Volume: 12, Issue:10 Topics: Adenosine; Animals; Apoptosis; Autophagy; Cytoprotection; Diabetic Nephropathies; Disease Progression; Down-Regulation; Doxorubicin; Gene Silencing; Glycation End Products, Advanced; Inflammation; Male; Methyltransferases; Mice, Inbred C57BL; Models, Biological; Podocytes; RNA, Messenger; Sirtuin 1; Up-Regulation	2021
METTL3-mediated m Annals of the rheumatic diseases, 2022, Volume: 81, Issue:1 Topics: Adenosine; Animals; Autophagy; Autophagy-Related Protein 7; Cartilage, Articular; Cell Line; Cellular Senescence; Chondrocytes; Coculture Techniques; Disease Models, Animal; Disease Progression; Female; GATA4 Transcription Factor; Gene Expression; Humans; Immunoprecipitation; Male; Methylation; Methyltransferases; Mice; Middle Aged; Osteoarthritis; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Messenger; RNA, Small Interfering; Synoviocytes; Up-Regulation	2022
m Experimental & molecular medicine, 2021, Volume: 53, Issue:11 Topics: 3' Untranslated Regions; Adenosine; Aged; Aged, 80 and over; Apoptosis; Aquaporin 1; Cartilage, Articular; Cells, Cultured; Chondrocytes; Disease Progression; Extracellular Matrix; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; MicroRNAs; Middle Aged; Models, Biological; Osteoarthritis; Phosphate Transport Proteins; RNA Interference; RNA, Long Noncoding	2021
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. BMC cancer, 2021, Nov-21, Volume: 21, Issue:1 Topics: Adenosine; Disease Progression; Humans; Immune Checkpoint Proteins; Lymphocytes, Tumor-Infiltrating; Neoplasm Staging; Prognosis; Proportional Hazards Models; RNA-Seq; RNA, Long Noncoding; Survival Rate; Transcriptome; Treatment Outcome; Urinary Bladder Neoplasms	2021
ALKBH5 Is Lowly Expressed in Esophageal Squamous Cell Carcinoma and Inhibits the Malignant Proliferation and Invasion of Tumor Cells. Computational and mathematical methods in medicine, 2021, Volume: 2021 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Apoptosis; Cell Line, Tumor; Cell Proliferation; Computational Biology; Disease Progression; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Recombinant Proteins; Transfection	2021
Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression. Genes & genomics, 2022, Volume: 44, Issue:12 Topics: Adenosine; Disease Progression; Gastrointestinal Stromal Tumors; Humans; Methyltransferases; MicroRNAs	2022
IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6. The international journal of biochemistry & cell biology, 2022, Volume: 152 Topics: Adenosine; Blotting, Western; Disease Progression; Endometriosis; Female; GATA6 Transcription Factor; Homeodomain Proteins; Humans; Methyltransferases; Ovarian Diseases; Ovary; RNA; RNA-Binding Proteins; Transcription Factors	2022
CD38 Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Cell Count; Cell Proliferation; Cytokines; Disease Progression; Hepatitis A Virus Cellular Receptor 2; HIV Infections; Humans; Killer Cells, Natural; Transforming Growth Factor beta	2022
N EBioMedicine, 2019, Volume: 47 Topics: Adenosine; Adult; Aged; AlkB Homolog 5, RNA Demethylase; Animals; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Integrin alpha6; Male; Methyltransferases; Mice; Middle Aged; Neoplasm Grading; Neoplasm Staging; RNA, Messenger; Urinary Bladder Neoplasms	2019
CT Perfusion Versus Coronary CT Angiography in Patients With Suspected In-Stent Restenosis or CAD Progression. JACC. Cardiovascular imaging, 2020, Volume: 13, Issue:3 Topics: Adenosine; Aged; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Female; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Multidetector Computed Tomography; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Predictive Value of Tests; Prospective Studies; Stents; Treatment Outcome; Vasodilator Agents	2020
N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene, 2020, Jan-05, Volume: 722 Topics: Adenosine; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Humans; Methyltransferases; Proto-Oncogene Proteins c-bcl-2	2020
Linking Infection and Prostate Cancer Progression: Toll-like Receptor3 Stimulation Rewires Glucose Metabolism in Prostate Cells. Anticancer research, 2019, Volume: 39, Issue:10 Topics: Adenosine; Cell Line, Tumor; Disease Progression; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; PC-3 Cells; Poly I-C; Prostate; Prostatic Neoplasms; Receptors, Purinergic P1; Toll-Like Receptor 3	2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8 Journal for immunotherapy of cancer, 2019, 10-10, Volume: 7, Issue:1 Topics: Adenosine; Adult; Aged; Aged, 80 and over; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Disease Progression; Female; Humans; Lymphocytes, Tumor-Infiltrating; Male; Mechanistic Target of Rapamycin Complex 1; Middle Aged; Neoplasms; Primary Cell Culture; Receptor, Adenosine A2A; Signal Transduction; Tumor Escape; Tumor Microenvironment	2019
Enzyme activity of circulating CD73 in human serum. Methods in enzymology, 2019, Volume: 629 Topics: 5'-Nucleotidase; Adenosine; Antineoplastic Agents, Immunological; Cell Line, Tumor; Disease Progression; Enzyme Assays; GPI-Linked Proteins; Humans; Neoplasms; Patient Selection; Receptors, Purinergic P1; T-Lymphocytes	2019
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1. Molecular cancer, 2019, 12-10, Volume: 18, Issue:1 Topics: Adenosine; Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; MicroRNAs; Models, Biological; Neovascularization, Pathologic; RNA Interference; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2019
RETRACTED: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing Molecular therapy : the journal of the American Society of Gene Therapy, 2020, 02-05, Volume: 28, Issue:2 Topics: Adenosine; Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Methyltransferases; Mice; MicroRNAs; RNA Interference; Xenograft Model Antitumor Assays	2020
KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Molecular cancer, 2019, 12-19, Volume: 18, Issue:1 Topics: Adenosine; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; GATA3 Transcription Factor; Humans; Liver Neoplasms; Methylation; Mice; Models, Biological; Neoplasm Metastasis; Prognosis; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Antisense; RNA, Long Noncoding; Xenograft Model Antitumor Assays	2019
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Journal of hematology & oncology, 2020, 01-08, Volume: 13, Issue:1 Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Lipogenesis; Liver Neoplasms; Mice, Inbred BALB C; Mice, SCID; RNA, Long Noncoding; Up-Regulation	2020
N Gene, 2020, Mar-20, Volume: 731 Topics: A549 Cells; Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; RNA Stability; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-3	2020
Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma. Cancer medicine, 2020, Volume: 9, Issue:5 Topics: Adenosine; Biomarkers, Tumor; Carboxy-Lyases; Carcinoma, Hepatocellular; Cell Line, Tumor; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Methylation; Methyltransferases; Nomograms; Risk Factors; RNA, Messenger; ROC Curve; Suppressor of Cytokine Signaling Proteins; Transaminases	2020
Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway. Cell proliferation, 2020, Volume: 53, Issue:3 Topics: Adenosine; Animals; Disease Progression; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Methyltransferases; Mice, Inbred C57BL; Mice, Nude; MicroRNAs; Prognosis; Wnt Signaling Pathway	2020
CD73 on cancer-associated fibroblasts enhanced by the A Nature communications, 2020, 01-24, Volume: 11, Issue:1 Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Cancer-Associated Fibroblasts; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; Drug Synergism; Hematopoietic Stem Cells; Humans; Lymphocytes, Tumor-Infiltrating; Mice, Inbred C57BL; Models, Biological; Neutralization Tests; Receptor, Adenosine A2B; Transcriptome; Treatment Outcome; Tumor Microenvironment; Up-Regulation	2020
Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer. Clinical chemistry, 2020, 02-01, Volume: 66, Issue:2 Topics: Adenosine; Adult; Aged; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Antigens, Tumor-Associated, Carbohydrate; Area Under Curve; Biomarkers, Tumor; Carcinoembryonic Antigen; Disease Progression; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; RNA, Messenger; Stomach Neoplasms; Xenograft Model Antitumor Assays	2020
m Journal of cellular physiology, 2020, Volume: 235, Issue:9 Topics: Adenosine; Adult; Aged; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methylation; Middle Aged; Prognosis; Proportional Hazards Models; Protein Interaction Maps; Rectal Neoplasms; RNA; RNA Helicases; RNA-Binding Proteins; Transcriptome	2020
Multiple m BMC cancer, 2020, Feb-28, Volume: 20, Issue:1 Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Methyltransferases; Neoplasm Grading; Prognosis; RNA-Binding Proteins; Sequence Analysis, RNA	2020
GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation. Cellular & molecular biology letters, 2020, Volume: 25 Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromogranins; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gs; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Liver Neoplasms; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; RNA Interference; RNA, Long Noncoding; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2020
LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma. Molecular oncology, 2020, Volume: 14, Issue:6 Topics: Adenosine; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; HSP70 Heat-Shock Proteins; Humans; Male; Methylation; Methyltransferases; Middle Aged; Models, Biological; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Proteasome Endopeptidase Complex; Proteolysis; RNA Stability; RNA, Long Noncoding; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Y-Box-Binding Protein 1	2020
N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma. Oncology reports, 2020, Volume: 43, Issue:5 Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Neoplasm Staging; Nomograms; Sequence Analysis, RNA; Survival Analysis	2020
m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma. Experimental cell research, 2020, 07-01, Volume: 392, Issue:1 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Renal Cell; Cohort Studies; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Male; Methylation; Methyltransferases; Middle Aged; Predictive Value of Tests; Prognosis; RNA Processing, Post-Transcriptional; Survival Analysis; Transcriptome	2020
Deoxycholic acid modulates the progression of gallbladder cancer through N Oncogene, 2020, Volume: 39, Issue:26 Topics: Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Deoxycholic Acid; Disease Progression; Gallbladder Neoplasms; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; RNA Interference; Xenograft Model Antitumor Assays	2020
M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT. Aging, 2020, 06-11, Volume: 12, Issue:12 Topics: Adenosine; Biomarkers, Tumor; Carcinogenesis; Cluster Analysis; Computational Biology; Datasets as Topic; Disease Progression; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Male; Methylation; Middle Aged; Mouth Neoplasms; Principal Component Analysis; Prognosis; Risk Assessment; RNA Processing, Post-Transcriptional; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck	2020
Incremental prognostic value of aortic stiffness in addition to myocardial ischemia by cardiac magnetic resonance imaging. BMC cardiovascular disorders, 2020, 06-11, Volume: 20, Issue:1 Topics: Adenosine; Aged; Aged, 80 and over; Disease Progression; Female; Heart Disease Risk Factors; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Observer Variation; Predictive Value of Tests; Prognosis; Pulse Wave Analysis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Time Factors; Vascular Stiffness	2020
Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies. Cell death & disease, 2020, 07-23, Volume: 11, Issue:7 Topics: Active Transport, Cell Nucleus; Adenosine; Animals; Cell Line, Tumor; Cell Nucleus; Disease Progression; Gene Expression Regulation, Leukemic; Gene Rearrangement; Humans; Leukemia; Male; Methyltransferases; Mice, Inbred NOD; Mice, SCID; Models, Biological; Nerve Tissue Proteins; Oncogene Proteins, Fusion; RNA Splicing Factors; RNA, Long Noncoding; RNA, Messenger; Serine-Arginine Splicing Factors	2020
RNA N Scientific reports, 2020, 08-12, Volume: 10, Issue:1 Topics: 3' Untranslated Regions; Adenosine; Adult; Apoptosis; Biomarkers, Tumor; Case-Control Studies; Cell Differentiation; Cell Proliferation; Disease Progression; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; N-Myc Proto-Oncogene Protein; Neoplasm Invasiveness; Neuroblastoma; Prognosis; RNA, Neoplasm; Survival Rate; Tumor Cells, Cultured	2020
RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway. Angiogenesis, 2021, Volume: 24, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Silencing; Hippo Signaling Pathway; Humans; Liver Neoplasms; Methylation; Methyltransferases; Mice, Inbred BALB C; Mice, Nude; Molecular Mimicry; Prognosis; Protein Biosynthesis; Protein Serine-Threonine Kinases; RNA; RNA, Messenger; Signal Transduction; Transcription Factors; Xenograft Model Antitumor Assays; YAP-Signaling Proteins	2021
Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma. Scientific reports, 2020, 09-15, Volume: 10, Issue:1 Topics: Adenosine; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cohort Studies; Computational Biology; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genes, Regulator; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Prognosis; Protein Interaction Maps; RNA, Long Noncoding; Signal Transduction	2020
Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. Journal of experimental & clinical cancer research : CR, 2020, Oct-21, Volume: 39, Issue:1 Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Microtubule-Associated Proteins; Prognosis; Prostatic Neoplasms; Retinoblastoma-Binding Protein 2; RNA-Binding Proteins; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2020
Cancer research, 2021, 02-15, Volume: 81, Issue:4 Topics: Adenosine; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Disease Progression; DNA Methylation; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Kidney Neoplasms; Methyltransferases; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; RNA-Binding Proteins; RNA, Long Noncoding	2021
ALKBH5-mediated m Aging, 2021, 01-10, Volume: 13, Issue:3 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Demethylation; Disease Progression; Epithelial-Mesenchymal Transition; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Uveal Neoplasms	2021
Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression. Aging, 2021, 01-10, Volume: 13, Issue:3 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Carcinogenesis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; delta-1-Pyrroline-5-Carboxylate Reductase; Disease Progression; Gene Knock-In Techniques; Gene Knockdown Techniques; Humans; Methylation; Mice; Neoplasm Staging; Neoplasm Transplantation; Pyrroline Carboxylate Reductases; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Ubiquitin Thiolesterase; Urinary Bladder Neoplasms	2021
METTL3 restrains papillary thyroid cancer progression via m Molecular therapy : the journal of the American Society of Gene Therapy, 2021, 05-05, Volume: 29, Issue:5 Topics: Adenosine; Animals; Disease Progression; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Male; Methyltransferases; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neutrophil Infiltration; Prognosis; Proto-Oncogene Proteins c-rel; Sequence Analysis, RNA; Thyroid Cancer, Papillary; Thyroid Neoplasms	2021
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma. BioMed research international, 2021, Volume: 2021 Topics: Adenosine; Disease Progression; DNA Copy Number Variations; Gene Expression Regulation, Neoplastic; Genomics; Humans; Melanoma; Polymorphism, Single Nucleotide; Skin Neoplasms; Transcriptome; Unsupervised Machine Learning	2021
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs. Nucleic acids research, 2021, 03-18, Volume: 49, Issue:5 Topics: Adenosine; Animals; Cell Hypoxia; Cell Line; Disease Progression; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidative Stress; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Transcriptome; Ubiquitination	2021
RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance. British journal of cancer, 2021, Volume: 124, Issue:10 Topics: Adenosine; Autophagy; Disease Progression; Drug Resistance, Neoplasm; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Processing, Post-Transcriptional	2021
CircPTPRA blocks the recognition of RNA N Molecular cancer, 2021, 04-14, Volume: 20, Issue:1 Topics: Adenosine; Animals; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Epigenesis, Genetic; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heterografts; Humans; Immunohistochemistry; Mice; Models, Biological; Protein Binding; Receptor-Like Protein Tyrosine Phosphatases, Class 4; RNA-Binding Proteins; RNA, Circular; Urinary Bladder Neoplasms	2021
CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression. International journal of biological sciences, 2021, Volume: 17, Issue:5 Topics: Adenosine; Breast Neoplasms; Carcinogenesis; CDC2 Protein Kinase; Cell Movement; Cell Proliferation; Disease Progression; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; MicroRNAs; Neoplasm Invasiveness; RNA, Circular; Signal Transduction	2021
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma. Cancer letters, 2021, 07-28, Volume: 511 Topics: Adenosine; Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; ELAV-Like Protein 1; Female; Glioma; Heterografts; Humans; Isocitrate Dehydrogenase; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; RNA, Long Noncoding; Signal Transduction	2021
Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Aging, 2021, 04-21, Volume: 13, Issue:8 Topics: Adenosine; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Computational Biology; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Immune Checkpoint Inhibitors; Male; Methylation; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nomograms; RNA; RNA-Binding Proteins; Survival Analysis; Survival Rate; Tumor Microenvironment	2021
Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N Cancer science, 2021, Volume: 112, Issue:8 Topics: Adenosine; Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Methyl-CpG-Binding Protein 2; Methyltransferases; Mice; Neoplasm Transplantation; RNA Stability; Up-Regulation	2021
METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression. Oncology reports, 2021, Volume: 46, Issue:2 Topics: A549 Cells; Adenosine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Methyltransferases; Mice; Middle Aged; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Survival Analysis	2021
The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. The Journal of experimental medicine, 2021, 08-02, Volume: 218, Issue:8 Topics: Adenosine; Animals; Antiviral Agents; Cell Proliferation; Cell Survival; Cytomegalovirus Infections; Disease Progression; DNA-Binding Proteins; Homeostasis; Immunity; Interleukin-15; Killer Cells, Natural; Mice, Inbred C57BL; Neoplasms; RNA; RNA-Binding Proteins; Transcriptome	2021
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m Journal of hematology & oncology, 2021, 07-10, Volume: 14, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Adenosine; Animals; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methyltransferases; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; RNA Stability; RNA-Binding Proteins; RNA, Messenger	2021
Cigarette smoking induces aberrant N Cancer letters, 2021, 10-10, Volume: 518 Topics: A549 Cells; Adenosine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cigarette Smoking; Death-Associated Protein Kinases; Disease Progression; Down-Regulation; Gene Expression Regulation; HEK293 Cells; Humans; Lung Neoplasms; NF-kappa B; Nicotiana; Oncogenes; RNA, Messenger; Signal Transduction	2021
C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1. Cell death & disease, 2021, 07-26, Volume: 12, Issue:8 Topics: Adenosine; Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Disease Progression; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Male; Metabolome; Methylation; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neutrophils; Phosphopyruvate Hydratase; Phosphorylation; Principal Component Analysis; Promoter Regions, Genetic; Protein Stability; Receptor, Anaphylatoxin C5a; RNA Splicing Factors; Signal Transduction; Stochastic Processes; Survival Analysis; Tumor Suppressor Proteins; Up-Regulation	2021
Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells. Cancer science, 2021, Volume: 112, Issue:11 Topics: Adenosine; Aerobiosis; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Demethylation; Disease Progression; Drug Resistance, Neoplasm; Glioblastoma; Glycolysis; Humans; Neoplasm Proteins; Prognosis; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Long Noncoding; RNA, Messenger; Temozolomide	2021
METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis. Journal of clinical laboratory analysis, 2021, Volume: 35, Issue:9 Topics: Adenosine; Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Methyltransferases; Nerve Tissue Proteins; Prognosis; Survival Rate; Tumor Cells, Cultured	2021
Interaction of tau with HNRNPA2B1 and N Molecular cell, 2021, 10-21, Volume: 81, Issue:20 Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Animals; Case-Control Studies; Cerebral Cortex; Disease Models, Animal; Disease Progression; Female; HEK293 Cells; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Male; Methylation; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Protein Aggregates; Protein Aggregation, Pathological; RNA; RNA Processing, Post-Transcriptional; Severity of Illness Index; tau Proteins	2021
Incremental Value of Transthoracic Doppler Echocardiography-Assessed Coronary Flow Reserve in Patients With Suspected Myocardial Ischemia Undergoing Myocardial Perfusion Scintigraphy. Journal of the American Heart Association, 2017, Apr-18, Volume: 6, Issue:4 Topics: Adenosine; Aged; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Echocardiography, Doppler; Feasibility Studies; Female; Fractional Flow Reserve, Myocardial; Humans; Kaplan-Meier Estimate; Male; Microcirculation; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Myocardial Perfusion Imaging; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2017
Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in Coronary Artery Disease. JACC. Cardiovascular imaging, 2017, Volume: 10, Issue:11 Topics: Adenosine; Aged; Angina, Unstable; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Vasodilator Agents	2017
Prognostic Value of Quantitative Stress Perfusion Cardiac Magnetic Resonance. JACC. Cardiovascular imaging, 2018, Volume: 11, Issue:5 Topics: Adenosine; Adult; Aged; Coronary Artery Disease; Coronary Circulation; Disease Progression; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Risk Factors; Time Factors; Vasodilator Agents	2018
T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients. Cancer letters, 2018, 03-28, Volume: 417 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Immune Tolerance; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Neoplasm Staging; Sentinel Lymph Node; Skin Neoplasms; T-Lymphocytes, Regulatory	2018
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nature communications, 2018, 01-31, Volume: 9, Issue:1 Topics: 3' Untranslated Regions; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Inosine; Melanoma; Mice; Mice, Nude; Microfilament Proteins; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogenes; RNA Editing; Skin Neoplasms	2018
Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury. The journal of trauma and acute care surgery, 2018, Volume: 84, Issue:6 Topics: Adenosine; Animals; Brain Injuries, Traumatic; Disease Models, Animal; Disease Progression; Fluid Therapy; Lidocaine; Magnesium; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Resuscitation	2018
m Biochemical and biophysical research communications, 2018, 08-25, Volume: 502, Issue:4 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Kruppel-Like Transcription Factors; Lung Neoplasms; Oncogenes; Prognosis; RNA Stability; RNA, Messenger; RNA, Neoplasm	2018
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth. Molecular neurobiology, 2019, Volume: 56, Issue:5 Topics: 5'-Nucleotidase; Adenosine; Animals; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Down-Regulation; Gene Knockdown Techniques; Glioblastoma; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats; Receptors, Purinergic P1; Signal Transduction; Temozolomide; Vimentin	2019
m Cell death & disease, 2018, 12-05, Volume: 9, Issue:12 Topics: Adenosine; Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; DNA Methylation; Epigenesis, Genetic; Female; Fibroblast Growth Factors; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Signal Transduction; Survival Analysis; Transcription Factors; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays	2018
Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic acids research, 2019, 03-18, Volume: 47, Issue:5 Topics: Adenosine; AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase; Animals; Apoptosis; Cell Movement; Cell Proliferation; Cytidine; Disease Progression; HeLa Cells; Humans; Mice; Neoplasm Invasiveness; Neoplasms; Ribonuclease, Pancreatic; RNA, Transfer; Xenograft Model Antitumor Assays	2019
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Molecular cancer, 2019, 03-28, Volume: 18, Issue:1 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cell Movement; Cell Proliferation; Demethylation; Disease Progression; Epigenesis, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Invasiveness; Prognosis; Proto-Oncogene Proteins; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019
Changes of N6-methyladenosine modulators promote breast cancer progression. BMC cancer, 2019, Apr-05, Volume: 19, Issue:1 Topics: Adenosine; Adult; Breast; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Datasets as Topic; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Methylation; Methyltransferases; Middle Aged; Mutation; Oxidoreductases, N-Demethylating; Prognosis; RNA, Messenger	2019
Excessive miR-25-3p maturation via N Nature communications, 2019, 04-23, Volume: 10, Issue:1 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Transformation, Neoplastic; Co-Repressor Proteins; Disease Progression; DNA Methylation; Epithelial Cells; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Male; Methyltransferases; MicroRNAs; Middle Aged; Nicotiana; Nuclear Proteins; Pancreatic Ducts; Pancreatic Neoplasms; Phosphoprotein Phosphatases; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; Repressor Proteins; Ribosomal Protein S6 Kinases, 70-kDa; RNA-Binding Proteins; Smoke; Smoking; Up-Regulation	2019
Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Journal of cellular physiology, 2020, Volume: 235, Issue:1 Topics: Actins; Adenosine; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Databases, Genetic; Disease Progression; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Profiling; Humans; Male; Methyltransferases; Neoplasm Staging; Prognosis; RNA Interference; RNA, Messenger; RNA, Small Interfering; Stomach Neoplasms; Transcription Factors	2020
The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1. Biochemical and biophysical research communications, 2019, 08-27, Volume: 516, Issue:3 Topics: Adenosine; Adolescent; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Child; Disease Progression; Humans; Lymphoid Enhancer-Binding Factor 1; Methylation; Methyltransferases; Osteosarcoma; RNA Interference; RNA, Messenger; Wnt Signaling Pathway	2019
The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1. Journal of cellular biochemistry, 2020, Volume: 121, Issue:1 Topics: Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Animals; Cell Cycle Proteins; Disease Progression; DNA Methylation; Humans; Male; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Protective Agents; Reperfusion Injury; Signal Transduction; Transcription Factors; YAP-Signaling Proteins	2020
Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. Cancer research, 2014, Feb-01, Volume: 74, Issue:3 Topics: Adenosine; Adenosine Deaminase; Carcinoma, Squamous Cell; Carrier Proteins; Cell Line, Tumor; Cohort Studies; Disease Progression; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inosine; Oncogene Proteins; RNA Editing; RNA-Binding Proteins	2014
A novel IKKα inhibitor, noraristeromycin, blocks the chronic inflammation associated with collagen-induced arthritis in mice. Modern rheumatology, 2014, Volume: 24, Issue:5 Topics: Adenosine; Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Disease Progression; Drug Administration Schedule; I-kappa B Kinase; Inflammation; Mice	2014
Adenosine pathway and cancer: where do we go from here? Expert opinion on therapeutic targets, 2014, Volume: 18, Issue:9 Topics: 5'-Nucleotidase; Adenosine; Animals; Antineoplastic Agents; Disease Progression; Drug Design; Humans; Molecular Targeted Therapy; Neoplasms; Receptors, Purinergic P1; Signal Transduction; Tumor Microenvironment	2014
Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. PloS one, 2014, Volume: 9, Issue:8 Topics: Adenosine; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Excitatory Postsynaptic Potentials; Humans; Male; Mice, Transgenic; Motor Endplate; Mutation; Neuromuscular Junction; Phenethylamines; Receptor, Adenosine A2A; Superoxide Dismutase; Synaptic Transmission	2014
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:4 Topics: Adenosine; Animals; Antineoplastic Agents; Cell Physiological Phenomena; Disease Progression; Drug Screening Assays, Antitumor; Humans; Inosine; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Staging; Neovascularization, Pathologic; Paclitaxel; Receptor, Adenosine A3; Tumor Cells, Cultured	2014
Clinical usefulness of nonhyperemic baseline Pd/Pa as a hybrid baseline Pd/Pa-fractional flow reserve strategy. Coronary artery disease, 2015, Volume: 26, Issue:1 Topics: Adenosine; Aged; Aorta; Arterial Pressure; Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Disease Progression; Disease-Free Survival; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Kaplan-Meier Estimate; Male; Middle Aged; Minnesota; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Time Factors; Vasodilator Agents	2015
DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Cancer letters, 2015, Apr-10, Volume: 359, Issue:2 Topics: Adenosine; Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Decitabine; Disease Progression; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Silencing; Glioblastoma; Histones; Humans; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Polycomb Repressive Complex 2; Stomach Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2015
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nature cell biology, 2015, Volume: 17, Issue:3 Topics: Adenosine; Adenosine Deaminase; Animals; Base Sequence; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Inosine; Luciferases; Melanoma; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Neoplasm Metastasis; Neoplasm Transplantation; RNA Editing; RNA-Binding Proteins; Skin Neoplasms; Transcription Factors	2015
Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology, 2015, Volume: 99 Topics: Adenosine; Animals; Anticonvulsants; Diet, Ketogenic; Disease Models, Animal; Disease Progression; DNA Methylation; Hippocampus; Kindling, Neurologic; Male; Mice; Pentylenetetrazole; Pilocarpine; Random Allocation; Rats, Wistar; Seizures; Status Epilepticus; Valproic Acid	2015
Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression. Advances in experimental medicine and biology, 2016, Volume: 876 Topics: Adenosine; Cell Hypoxia; Disease Progression; Humans; Neoplasms; Tumor Microenvironment	2016
Activation of the adenosine A2A receptor attenuates experimental autoimmune encephalomyelitis and is associated with increased intracellular calcium levels. Neuroscience, 2016, 08-25, Volume: 330 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Body Weight; Calcium; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Immunologic Factors; Intracellular Space; Lymphocytes; Mice, Inbred C57BL; Myelin Sheath; Phenethylamines; Receptor, Adenosine A2A; Severity of Illness Index; Spinal Cord	2016
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. Translational research : the journal of laboratory and clinical medicine, 2017, Volume: 182 Topics: Adenosine; Animals; Disease Progression; Enzyme Activation; Hepatocytes; Inflammation; Lipids; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phenethylamines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A2A; Signal Transduction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory	2017
The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2017, Jan-09, Volume: 19, Issue:1 Topics: Adenosine; Adult; Aged; Arterial Pressure; Biomarkers; Cardiorespiratory Fitness; Disease Progression; Elastic Modulus; Female; Hemodynamics; Humans; Hyperemia; Hypertension, Pulmonary; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Pulmonary Artery; Stroke Volume; Time Factors; Vascular Resistance; Vascular Stiffness; Vasodilator Agents; Ventricular Function, Right; Walk Test	2017
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A. Molecular therapy : the journal of the American Society of Gene Therapy, 2017, 01-04, Volume: 25, Issue:1 Topics: Adenosine; Animals; Biomarkers; Carbon Tetrachloride; Collagen Type I; Disease Models, Animal; Disease Progression; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation; Hepatic Stellate Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Liver Cirrhosis; Male; Mice; Myofibroblasts	2017
m Cell reports, 2017, 03-14, Volume: 18, Issue:11 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Base Sequence; Brain Neoplasms; Carcinogenesis; Cell Differentiation; Cell Proliferation; Cell Self Renewal; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Humans; Meclofenamic Acid; Methylation; Methyltransferases; Mice; Neoplastic Stem Cells; RNA; RNA, Messenger	2017
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. Journal of vascular surgery, 2009, Volume: 49, Issue:3 Topics: Adenosine; Adenosine Diphosphate; Animals; Aorta; Aortic Aneurysm, Abdominal; Blood Platelets; Disease Models, Animal; Disease Progression; Elastic Tissue; Guinea Pigs; Inflammation; Male; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred Lew; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Time Factors; Transplantation, Heterologous	2009
Adenosine receptors in COPD and asymptomatic smokers: effects of smoking cessation. Virchows Archiv : an international journal of pathology, 2009, Volume: 454, Issue:3 Topics: Adenosine; Adult; Bronchoscopy; Chromatography, High Pressure Liquid; Disease Progression; Female; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Receptors, Purinergic P1; Smoking; Smoking Cessation; Sputum	2009
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. The European journal of neuroscience, 2009, Volume: 30, Issue:6 Topics: Adenosine; Age Factors; Analysis of Variance; Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Electroencephalography; Epilepsy, Absence; Glutamic Acid; Immunohistochemistry; Male; MAP Kinase Signaling System; Microinjections; Phenethylamines; Pyrimidines; Rats; Receptor, Adenosine A2A; Somatosensory Cortex; Thalamus; Triazoles	2009
Adenosine during arrhythmia. American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2010, Volume: 19, Issue:2 Topics: Adenosine; Anti-Arrhythmia Agents; Contraindications; Disease Progression; Electrocardiography; Humans; Male; Middle Aged; Tachycardia	2010
The timing and impact of follow-up studies after normal stress single-photon emission computed tomography sestamibi studies. Circulation. Cardiovascular imaging, 2010, Volume: 3, Issue:5 Topics: Adenosine; Aged; Chi-Square Distribution; Databases as Topic; Disease Progression; Exercise Test; Female; Heart Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Minnesota; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2010
Single-photon emission computed tomography perfusion imaging: is using a "warranty period" warranted? Circulation. Cardiovascular imaging, 2010, Volume: 3, Issue:5 Topics: Adenosine; Disease Progression; Exercise Test; Heart Diseases; Humans; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2010
Adenosine 2A receptor is protective against renal injury in MRL/lpr mice. Lupus, 2011, Volume: 20, Issue:7 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Female; Gene Expression; Inflammation; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Phenethylamines; Receptor, Adenosine A2A; Reverse Transcriptase Polymerase Chain Reaction; RNA	2011
Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice. PloS one, 2010, Dec-29, Volume: 5, Issue:12 Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cyclin D1; Cytokines; Disease Progression; Fibroblasts; Fibrosis; Inflammation; Liver; Liver Diseases; Mice; Mice, Transgenic; Proto-Oncogene Proteins c-jun; Thionucleosides	2010
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. The Journal of clinical investigation, 2011, Volume: 121, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Disease Progression; Female; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Lymphoma, Non-Hodgkin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Targeted Therapy; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Chimera; Second Messenger Systems; T-Lymphocytes; T-Lymphocytes, Regulatory; Tumor Burden	2011
Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging. The international journal of cardiovascular imaging, 2012, Volume: 28, Issue:5 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Coronary Artery Disease; Coronary Circulation; Disease Progression; Disease-Free Survival; Dobutamine; Female; Germany; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multivariate Analysis; Myocardial Contraction; Myocardial Infarction; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors	2012
CD39/adenosine pathway is involved in AIDS progression. PLoS pathogens, 2011, Volume: 7, Issue:7 Topics: Adenosine; Antigens, CD; Apyrase; Biomarkers; Bulgaria; Cell Proliferation; Cells, Cultured; Disease Progression; Down-Regulation; Forkhead Transcription Factors; France; Gene Expression; HIV Infections; Humans; Lymphocyte Activation; Polymorphism, Genetic; Receptor, Adenosine A2A; Survival Rate; T-Lymphocytes, Regulatory	2011
CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. The Journal of rheumatology, 2011, Volume: 38, Issue:10 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Arthritis, Experimental; Cartilage, Articular; Collagen Type II; Cyclooxygenase 2; Disease Progression; Interleukin-6; Joints; Mice; Nitric Oxide Synthase Type II; Phenethylamines; Tumor Necrosis Factor-alpha	2011
The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease. American heart journal, 2011, Volume: 162, Issue:2 Topics: Adenosine; Alaska; Anti-Arrhythmia Agents; Chronic Disease; Coronary Disease; Diabetes Mellitus; Disease Progression; Female; Follow-Up Studies; Heart Rate; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors	2011
Adenosine stress high-pitch 128-slice dual-source myocardial computed tomography perfusion for imaging of reversible myocardial ischemia: comparison with magnetic resonance imaging. Circulation. Cardiovascular imaging, 2011, Volume: 4, Issue:5 Topics: Adenosine; Aged; Aged, 80 and over; Coronary Circulation; Disease Progression; Exercise Test; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Prospective Studies; Recovery of Function; Reproducibility of Results; Severity of Illness Index; Tomography, X-Ray Computed; Vasodilator Agents	2011
Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice. Cardiovascular research, 2011, Nov-01, Volume: 92, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Chemokine CCL2; Cholesterol; Disease Models, Animal; Disease Progression; Fatty Acids, Nonesterified; Gene Expression Profiling; GPI-Linked Proteins; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; T-Lymphocytes; Time Factors; Triglycerides	2011
Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells. Blood, 2012, Feb-02, Volume: 119, Issue:5 Topics: Adenosine; Animals; Apoptosis; Cells, Cultured; Disease Progression; Enzyme Inhibitors; Graft vs Host Disease; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Isoantigens; Lymphocyte Activation; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Substrate Specificity; T-Lymphocytes; Up-Regulation	2012
Rapid progression of coronary aneurysm to stenosis in a patient with Kawasaki disease. The Journal of invasive cardiology, 2012, Volume: 24, Issue:1 Topics: Adenosine; Child, Preschool; Coronary Aneurysm; Coronary Stenosis; Disease Progression; Echocardiography; Fractional Flow Reserve, Myocardial; Humans; Male; Mucocutaneous Lymph Node Syndrome; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents	2012
Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PloS one, 2012, Volume: 7, Issue:6 Topics: Adenosine; Adenosine A2 Receptor Agonists; Amyotrophic Lateral Sclerosis; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Disease Progression; Mice; Phenethylamines; Receptor, trkB; Superoxide Dismutase	2012
The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:2 Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Bone and Bones; Cell Movement; Disease Progression; Female; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3	2013
The predictive value of chronic kidney disease for assessing cardiovascular events under consideration of pretest probability for coronary artery disease in patients who underwent stress myocardial perfusion imaging. The international journal of cardiovascular imaging, 2013, Volume: 29, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Angina, Unstable; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Predictive Value of Tests; Probability; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2013
Adenosine-induced worsening of supraventricular tachycardia. BMJ case reports, 2012, Dec-10, Volume: 2012 Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Disease Progression; Humans; Tachycardia, Supraventricular	2012
Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. Journal of the American College of Cardiology, 2003, Sep-03, Volume: 42, Issue:5 Topics: Adenosine; Age Factors; AMP-Activated Protein Kinases; Animals; Anti-Arrhythmia Agents; Biopsy; Cardiomegaly; Disease Models, Animal; Disease Progression; Electrocardiography; Electrophysiologic Techniques, Cardiac; Electrophysiology; Genotype; Heart Conduction System; Mice; Mice, Transgenic; Multienzyme Complexes; Mutation, Missense; Phenotype; Pre-Excitation Syndromes; Procainamide; Protein Serine-Threonine Kinases; Single-Blind Method; Ventricular Dysfunction; Wolff-Parkinson-White Syndrome	2003
Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jan-15, Volume: 10, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Adenosine Monophosphate; Adenosine Triphosphate; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Progression; Estradiol; Estrogens; Gene Expression Regulation, Neoplastic; Genes, Dominant; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Phorbol Esters; Plasmids; Receptors, Estrogen; RNA, Messenger; Time Factors; Transfection	2004
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Feb-11, Volume: 24, Issue:6 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation	2004
Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation, 2004, Nov-02, Volume: 110, Issue:18 Topics: Adenosine; Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Hemodynamics; Humans; Hyperemia; Life Tables; Male; Middle Aged; Myocardial Infarction; Pressure; Single-Blind Method; Transducers, Pressure; Ultrasonography, Interventional	2004
AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression. Circulation, 1999, Mar-23, Volume: 99, Issue:11 Topics: Adenosine; Adenosine Monophosphate; Alleles; AMP Deaminase; Cardiomyopathy, Dilated; Disease Progression; Energy Metabolism; Genetic Predisposition to Disease; Genotype; Heart Failure; Humans; Myocardium; Receptors, Purinergic P1	1999
Adenosine A(1)-receptor induced late preconditioning and myocardial infarction: reperfusion duration is critical. American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:1 Topics: Adenosine; Animals; Cardiac Catheterization; Coronary Vessels; Disease Models, Animal; Disease Progression; Heart Ventricles; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Agonists; Rabbits; Receptors, Purinergic P1; Time Factors; Treatment Outcome; Wakefulness	2002